170529 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Porphyrin- or corrin-ring-containing peptides Cytochromes
ENZYME-IMMOBLIZED PARTICLES FOR ONLINE PROTEIN DIGESTION
#2INTEGRATED ELECTROCHEMICAL APTASENSORS FOR MEASURING CELL DEATH AND CYTOKINE ACTIVITY FROM INTACT TISSUE SAMPLES
#3METHOD FOR EVALUATING EFFECT OF CYTOKINE ON METABOLIC ACTIVITY OF CYTOCHROME P450, AND DRUG SCREENING METHOD
#4METABOLIC RESTRICTION IN CELL-BASED ASSAYS
#5XANTHINE COMPOUND AND USE THEREOF
#6AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#7Biosensor incorporating protein-immobilized membrane and method of immobilizing protein in biosensor
#8Plasma cytochrome C as a biomarker for mitochondrial toxicity during antiretroviral therapy
#9Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#10Method for evaluating effect of cytokine on metabolic activity of cytochrome P450, and drug screening method
#11Biomarker to Measure Drug Efficacy in Enteropathic Disease
#12Protein-immobilized electrode and method of manufacturing the same, and functional element and method of manufacturing the same
#13Recognition of CYP2E1 epitopes
#14DETECTION AND MODULATION OF CYTOCHROME C ACETYLATION
#15Methods of producing recombinant heme-binding proteins and uses thereof
#16SCREENING FOR MODULATORS OF CYP2B15 AND/OR GPD1 FOR THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#17Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#18Cytochrome synthesis inhibitors
#19METHOD FOR NON-INVASIVE EXAMINATION OF NON-ALCOHOLIC STEATOHEPATITIS BY QUANTIFICATION OF CYTOCHROME-c, AND TEST KIT
#20Protein-Immobilized membrane, method for immobilization of protein, enzyme-immobilized electrode, and biosensor
#21Method Of Screening Candidate Drug
#22Cytochrome C And Leucine-Rich Alpha-2-Glycoprotein-1 Assays, Methods, And Antibodies
#23USE OF RAMAN SPECTROSCOPY IN ENZYME ACTIVITY ASSAYS
#24Cytochrome c synthesis inhibitors
#25Method for the detection of apoptosis by determining apoptosis-specific markers released into an extracellular medium through cellular release mechanisms
#26Cytochrome and leucine-rich alpha-2-glycoprotein-1 assays, methods and antibodies
#27Agents that bind to and inhibit human cytochrome P450 2C19
#28Detection of biomolecules by sensitizer-linked substrates
#29Analysis of protein isoforms using unique tryptic peptides by mass spectrometry and immunochemistry
#30Genetic markers for skatole metabolism
#31Direct measurement of sorption on three-dimensional surfaces such as resins, membranes or other preformed materials using lateral dispersion to estimate rapid sorption kinetics or high binding capacities
#32Variants of cytochrome c and methods of diagnosis of thrombocytopenia
#33Method for optimizing therapeutic efficacy of nemorubicin
#34Novel enzymes and metabolites involved in skatole metabolism
#35Method for determining the regulation of xenobiotic removal
#36Stable expression of polymorphous forms of human cytochrome p450 2d6
#37Agents that bind to and inhibit human cytochrome P450 2C19